HSC R&D Division supports research studies that address the current COVID-19 pandemic.
| TITLE | CHIEF INVESTIGATOR | DATES | COST TO HSC R&D |
|---|---|---|---|
| SIREN: SarsCov2 Immunity and REinfection EvaluatioN | Prof Nigel Hart | 2021-23 | £274,811 |
| Biological profiling in COVID-19 infection to characterise optimal therapeutic approaches | Prof Danny McAuley (QUB) | 2022 | £8,926 |
| Provision of Convalescent Plasma as a potential clinical trial treatment option for patients with COVID-19 in NI | Ms Barbara Mullin (NI Blood Transfusion Service) | 2021-22 | £101,662 |
|
Impact of COVID-19 on mental health in Northern Ireland: an administrative data linkage study |
Dr Aideen Maguire (QUB) | 2021-22 | £163,349 |
|
Senescence biomarkers for predicting risk in Covid-19 patients Publications: Senescence Signatures Predict Hospitalization Risk and Severity in COVID-19 Patients Senescence Biomarkers CKAP4 and PTX3 Stratify Severe Kidney Disease Patients |
Dr Taranjit Singh Rai (UU) | 2020-22 | £197,396 |
| Estimate of Northern Ireland community seroprevalence of antibodies against SARS-CoV-2 from anonymised residual blood samples | Prof Chris Scott (QUB) | 2020-21 | £10,183 |
|
Repurposing FDA-approved drugs for treatment of 2019-nCoV-induced disease. |
Professor Ultan Power (QUB) |
2020-21 | £208,070 |
|
Necessary discussions: Advance care planning for nursing homes in a COVID-19 outbreak (Awarded co-funded with UKRI ESRC) Evidence Brief, Outcomes paper, Protocol paper **Resources: https://covidacpcarehomes.com
|
Professor Kevin Brazil (QUB) | 2020-21 | £131,697 |
|
A mixed methods study of the community pharmacy workforce’s preparedness for, and response to, the COVID-19 pandemic **Report - Executive Summary |
Professor Carmel Hughes (QUB) | 2020-21 | £63,829 |
|
Effectiveness of staff well-being interventions in response to COVID-19 in Northern Ireland Click here to access publication**
|
Dr Ciaran Shannon (NHSCT) | 2020-21 | £68,274 |
|
The REALIST Study (Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration): Re-purposed to recruit patients with ARDS secondary to COVID-19 |
Professor Danny McAuley (QUB/BHSCT) | 2020-21 | £282,736 |
|
A survey of hospital dialysis patients during the COVID-19 pandemic in Northern Ireland |
Professor Joanne Reid (QUB) | 2020 | £4,993 |
|
COVID-19 Possible options for analysis and intervention via social media
|
Professor Frank Kee (QUB) | 2020-21 | £42,000 |
|
Modulation of the innate immune response to SARS-CoV-2 with bradykinin inhibition
|
Dr Joe Kidney (BHSCT) | 2020-21 | £78,500 |
|
Health & Social Care Workers’ quality of working life and coping while working during COVID-19 Pandemic
|
Dr Paula McFadden (UU) | 2020-21 | £70,000 |
|
Seroprevalence of SARS-Cov-2 infection in healthy children across the UK Click here for publications 1** 2** 3**
|
Dr Thomas Waterfield (QUB) | 2020 | £18,750 |